HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zhang, D Articles by Wise, C A Search for Related Content PubMed PubMed Citation Articles by Zhang, D Articles by Wise, C A Pubmed/NCBI databases Genetics Home Reference Medline Plus Health Information Joint Disorders Topic Collections JMG Online mutation reports

Mutations responsible for Larsen syndrome cluster in the FLNB protein

¹ Seay Center for Musculoskeletal Research, Texas Scottish Rite Hospital for Children, Dallas, Texas, USA
² Department of Orthopedics, Texas Scottish Rite Hospital for Children
³ Clinical Laboratory, Texas Scottish Rite Hospital for Children

Correspondence to:
Dr Carol A Wise
Seay Center for Musculoskeletal Research, Texas Scottish Rite Hospital for Children, 2222 Welborn St, Dallas, TX 75219, USA; carol.wise{at}tsrh.org] Background: A gene for Larsen syndrome was recently described, and mutations were reported in five cases.

Objective: To test whether mutations in this gene, FLNB, could explain the disease in our independent collection of sporadic and dominant Larsen syndrome cases; and to test whether mutations occurred in a non-random pattern.

Results: Missense mutations were found in each of five cases. Four of the five were new; one was reported in a sporadic case in the original Larsen syndrome study of five cases. All mutations from the two studies were compiled. Clustered mutations were observed within three filamin B protein domains: the calponin homology 2 domain, repeat 14, and repeat 15. This suggested that as few as five (of the total of 46) coding exons of FLNB could be screened to detect Larsen syndrome mutations. Four of these exons were screened in a sixth (sporadic) case and a previously reported G1691S substitution mutation detected.

Conclusions: Mutations in FLNB may be responsible for all cases of Larsen syndrome. They appear to occur in specific functional domains of the filamin B protein. This should simplify diagnostic screening of the FLNB gene. Analyses in larger patient series are warranted to quantify this. The study confirmed the extreme variability in clinical presentation and the presence of unaffected carriers. A molecular screen would be valuable for diagnosis and genetic counselling.

Abbreviations: ABD, actin binding domain; CHD, calponin homology domain; MNS, Melnick-Needles syndrome; OPD, otopalatodigital syndrome; PVNH, periventricular nodular heterotopia

Keywords: Larsen syndrome; skeletal/craniofacial development; genetic heterogeneity; mutation detection

This article has been cited by other articles:

				L. Zheng, H.-J. Baek, G. Karsenty, and M. J. Justice Filamin B represses chondrocyte hypertrophy in a Runx2/Smad3-dependent manner J. Cell Biol., October 3, 2007; 178(1): 121 - 128. [Abstract] [Full Text] [PDF]